Activated Carbon for Pharmaceutical Manufacturing Purification

More than an input—a critical quality system component.

Pharmaceutical manufacturing operates under the most exacting purity standards in industry. We are not discussing ppm-level control, but ppb and below; not general compliance, but full traceability for endotoxins, heavy metals, and organic residues across every production lot. A trace heavy metal in an active ingredient, or an endotoxin excursion in an injectable solution, can scrap millions in inventory and trigger regulatory recall. The carbon is not merely an input; it is a vital quality system component.

The Challenge & PureStar Approach

The Core Challenge: Turning the purifier into a polluter—avoiding secondary contamination.

The paradoxical risk is that carbon can release endotoxins, metal impurities, or organic leachables back into the purification stream. With ICH Q3D elemental impurity guidelines and tightening pharmacopeial limits, the requirement has shifted from "effective decolorization" to "end-to-end quality guarantee."